Brief: SELLAS Life Sciences Group, Inc. Q2 basic EPS USD -0.31
10/08/2023 21:09
Aug 10 (Reuters) - SELLAS Life Sciences Group, Inc. Q2 operating expenses USD 9.05 million. * Q2 net income USD -8.84 million * Q2 basic EPS USD -0.31 * Q2 operating income USD -9.05 million
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses